Patents by Inventor Mei-June Liao

Mei-June Liao has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5989441
    Abstract: A method of recovering functional human leukocytes from blood filters used to deplete leukocyte content from leukocyte-containing blood-cell suspensions is provided. More particularly, this method involves isolating leukocytes from filters which have been used to purify red blood cells or platelets in isolation from leukocytes by back-flushing the used filters with a hemolysis solution, such as cold ammonium chloride, and collecting the functional human leukocytes.
    Type: Grant
    Filed: December 22, 1997
    Date of Patent: November 23, 1999
    Assignee: Interferon Science, Inc.
    Inventors: Abbas Rashidbaigi, Mei-June Liao, Ji Hua, Maninder Sidhu
  • Patent number: 5676942
    Abstract: This invention provides alpha interferon compositions comprising one or a mixture of selected highly antiviral interferon proteins, which compositions are characterized by increased anti-viral activity. These compositions may be used therapeutically in the treatment of viral infection, particularly retroviral or hepatitis infection or as additives to conventional antiviral agents to increase the antiviral potency thereof.
    Type: Grant
    Filed: May 25, 1995
    Date of Patent: October 14, 1997
    Assignee: Interferon Sciences, Inc.
    Inventors: Douglas Testa, Mei-June Liao, Katalin Ferencz-Biro, Abbas Rashidbaigi, Mario DiPaola
  • Patent number: 5516515
    Abstract: Two distinct alpha interferon receptor proteins have been separated and partially purified by antigen affinity chromatography and SDS-PAGE. These proteins are potentially useful as therapeutic agents. Antibodies against these proteins are potentially useful as diagnostic and therapeutic agents.
    Type: Grant
    Filed: May 3, 1990
    Date of Patent: May 14, 1996
    Assignee: Interferon Sciences, Inc.
    Inventors: Laura C. Vellucci, Steven R. Scott, Mei-June Liao, Douglas Testa
  • Patent number: 5503828
    Abstract: This invention provides a novel improved alpha interferon composition characterized by high specific activity, a purity of greater than 95% and which upon use in humans is further characterized by a substantial reduction in side effects normally associated with alpha interferon compositions. Also provided is a method for large scale production of the composition from human peripheral blood leukocytes. This alpha interferon composition may be used therapeutically in the treatment of cancers and diseases of the immune system and/or viral etiology.
    Type: Grant
    Filed: October 5, 1993
    Date of Patent: April 2, 1996
    Assignee: Interferon Sciences, Inc.
    Inventors: Douglas Testa, Mei-June Liao, Katalin Ferencz-Biro, Abbas Rashidbaigi, Mario DiPaola, Manisha Padhye